Skip to main content
Clinical Trials/DRKS00011260
DRKS00011260
Completed
Not Applicable

The continuum between healthy ageing and idiopathic Parkinson Disease within a propagation perspective of inflammation and damage: the search for new diagnostic, prognostic and therapeutic targets. Phase 2 - PROPAG-AGEING - Phase 2

IRCCS Istituto delle Scienze Neurologiche di Bologna0 sites345 target enrollmentNovember 9, 2016
ConditionsG20.9

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G20.9
Sponsor
IRCCS Istituto delle Scienze Neurologiche di Bologna
Enrollment
345
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2016
End Date
January 22, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
IRCCS Istituto delle Scienze Neurologiche di Bologna

Eligibility Criteria

Inclusion Criteria

  • 1\.Siblings of patients with a diagnosis of sporadic idiopathic Parkinson’s Disease, according to the International Diagnostic Criteria \[UK Brain Bank Criteria];
  • 2\.signed informed consent

Exclusion Criteria

  • 1\.Diagnosis of sporadic idiopathic Parkinson’s Disease according to the UK Brain Bank Criteria;
  • 2\.patients affected by clinically relevant diseases of the Central Nervous System (i.e. Alzheimer’s disease, Vascular Encephalopathies, Multiple Sclerosis, etc.).

Outcomes

Primary Outcomes

Not specified

Similar Trials